Translesion activity of PrimPol on DNA with cisplatin and DNA–protein cross-links

Elizaveta O. Boldinova, Anna V. Yudkina, Evgeniy S. Shilkin, Diana I. Gagarinskaya, Andrey G. Baranovskiy, Tahir H. Tahirov, Dmitry O. Zharkov, Alena V. Makarova

Research output: Contribution to journalArticlepeer-review

Abstract

Human PrimPol belongs to the archaeo-eukaryotic primase superfamily of primases and is involved in de novo DNA synthesis downstream of blocking DNA lesions and non-B DNA structures. PrimPol possesses both DNA/RNA primase and DNA polymerase activities, and also bypasses a number of DNA lesions in vitro. In this work, we have analyzed translesion synthesis activity of PrimPol in vitro on DNA with an 1,2-intrastrand cisplatin cross-link (1,2-GG CisPt CL) or a model DNA–protein cross-link (DpCL). PrimPol was capable of the 1,2-GG CisPt CL bypass in the presence of Mn2+ ions and preferentially incorporated two complementary dCMPs opposite the lesion. Nucleotide incorporation was stimulated by PolDIP2, and yeast Pol ζ efficiently extended from the nucleotides inserted opposite the 1,2-GG CisPt CL in vitro. DpCLs significantly blocked the DNA polymerase activity and strand displacement synthesis of PrimPol. However, PrimPol was able to reach the DpCL site in single strand template DNA in the presence of both Mg2+ and Mn2+ ions despite the presence of the bulky protein obstacle.

Original languageEnglish (US)
Article number17588
JournalScientific reports
Volume11
Issue number1
DOIs
StatePublished - Dec 2021

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Translesion activity of PrimPol on DNA with cisplatin and DNA–protein cross-links'. Together they form a unique fingerprint.

Cite this